Patents by Inventor Guity Balow

Guity Balow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Melanin concentrating hormone receptor antagonist
    Patent number: 7659276
    Abstract: Novel compounds, or pharmaceutically-acceptable salts, tautomers or prodrugs thereof, of Formula I wherein A, W, X, Z, R1-R3, and R8 are as defined in the specification, are provided. Also provided are methods of treating or preventing a melanin concentrating hormone-mediated disorder in a subject, comprising administering to a subject in need of such treatment or prevention a compound of Formula I.
    Type: Grant
    Filed: February 6, 2009
    Date of Patent: February 9, 2010
    Assignee: Amgen, Inc.
    Inventors: Christopher Hulme, Paul Tempest, Vu Ma, Thomas Nixey, Guity Balow
  • MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONIST
    Publication number: 20090143405
    Abstract: Novel compounds, or pharmaceutically-acceptable salts, tautomers or prodrugs thereof, of Formula I wherein A, W, X, Z, R1-R3, and R8 are as defined in the specification, are provided. Also provided are methods of treating or preventing a melanin concentrating hormone-mediated disorder in a subject, comprising administering to a subject in need of such treatment or prevention a compound of Formula I.
    Type: Application
    Filed: February 6, 2009
    Publication date: June 4, 2009
    Applicant: AMGEN, INC.
    Inventors: Christopher Hulme, Paul Tempest, Vu Van Ma, Thomas Nixey, Guity Balow
  • Melanin concentrating hormone receptor antagonist
    Patent number: 7514438
    Abstract: Novel compounds, or pharmaceutically-acceptable salts, tautomers or prodrugs thereof, of Formula I wherein A, W, X, Z, R1-R3, and R8 are as defined in the specification, are provided. Also provided are methods of treating or preventing a melanin concentrating hormone-mediated disorder in a subject, comprising administering to a subject in need of such treatment or prevention a compound of Formula I.
    Type: Grant
    Filed: August 11, 2004
    Date of Patent: April 7, 2009
    Assignee: Amgen, Inc.
    Inventors: Christopher Hulme, Paul A. Tempest, Vu Van Ma, Thomas Nixey, Guity Balow
  • Compounds and Uses Thereof in Modulating Amyloid Beta
    Publication number: 20070260058
    Abstract: Novel compounds, compositions, and kits are provided. Methods of modulating A? levels, and methods of treating a disease associated with aberrant A? levels are also provided.
    Type: Application
    Filed: July 17, 2007
    Publication date: November 8, 2007
    Inventors: Soan Cheng, Daniel Comer, Long Mao, Guity Balow, David Pleynet
  • COMPOUNDS AND USES THEREOF IN MODULATING AMYLOID BETA
    Publication number: 20070249833
    Abstract: Novel compounds, compositions, and kits are provided. Methods of modulating A? levels, and methods of treating a disease associated with aberrant A? levels are also provided.
    Type: Application
    Filed: June 19, 2007
    Publication date: October 25, 2007
    Inventors: Soan Cheng, Daniel Comer, Long Mao, Guity Balow, David Pleynet
  • Melanin concentrating hormone receptor antagonist
    Publication number: 20050215526
    Abstract: Novel compounds, or pharmaceutically-acceptable salts, tautomers or prodrugs thereof, of Formula I wherein A, W, X, Z, R1-R3, and R8 are as defined in the specification, are provided. Also provided are methods of treating or preventing a melanin concentrating hormone-mediated disorder in a subject, comprising administering to a subject in need of such treatment or prevention a compound of Formula I.
    Type: Application
    Filed: August 11, 2004
    Publication date: September 29, 2005
    Inventors: Christopher Hulme, Paul Tempest, Vu Ma, Thomas Nixey, Guity Balow
  • Compounds and uses thereof in modulating amyloid beta
    Publication number: 20050070538
    Abstract: Novel compounds, compositions, and kits are provided. Methods of modulating A? levels, and methods of treating a disease associated with aberrant A? levels are also provided.
    Type: Application
    Filed: May 14, 2004
    Publication date: March 31, 2005
    Inventors: Soan Cheng, Daniel Comer, Long Mao, Guity Balow, David Pleynet